Elizabeth A. Dietrich

Elizabeth A. Dietrich

Auto-generated profile, based on publicly available information

Elizabeth A. Dietrich

Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2015 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
NGNathan D. Grubaugh
Nathan D. Grubaugh
DSDarci R. Smith
Darci R. Smith
DBDoug E. Brackney
Doug E. Brackney
ABAngela M. Bosco-Lauth
Angela M. Bosco-Lauth
JFJoseph R. Fauver
Joseph R. Fauver
GEGreg Ebel
Greg Ebel
Within hosts, RNA viruses form populations that are genetically and phenotypically complex. Heterogeneity in RNA virus genomes arises due to error-prone replication and is reduced by stochastic and selective mechanisms that are incompletely understood. Defining how natural selection shapes RNA virus populations is critical because it can inform treatment paradigms and enhance control efforts. We allowed West Nile virus (WNV) to replicate in wild-caught American crows, house sparrows and American robins to assess how natural selection shapes RNA virus populations in ecologically relevant hosts that differ in susceptibility to virus-induced mortality. After five sequential passages in each bird species, we examined the phenotype and population diversity of WNV through fitness competition assays and next generation sequencing. We demonstrate that fitness gains occur in a species-specific manner, with the greatest replicative fitness gains in robin-passaged WNV and the least in WNV passaged in crows. Sequencing data revealed that intrahost WNV populations were strongly influenced by purifying selection and the overall complexity of the viral populations was similar among passaged hosts. However, the selective pressures that control WNV populations seem to be bird species-dependent. Specifically, crow-passaged WNV populations contained the most unique mutations (~1.7× more than sparrows, ~3.4× more than robins) and defective genomes (~1.4× greater than sparrows, ~2.7× greater than robins), but the lowest average mutation frequency (about equal to sparrows, ~2.6× lower than robins). Therefore, our data suggest that WNV replication in the most disease-susceptible bird species is positively associated with virus mutational tolerance, likely via complementation, and negatively associated with the strength of selection. These differences in genetic composition most likely have distinct phenotypic consequences for the virus populations. Taken together, these results reveal important insights into how different hosts may contribute to the emergence of RNA viruses. Viruses are constantly emerging into new areas and pose significant challenges to public health. Chikungunya and West Nile viruses (WNV), both mosquito-borne RNA viruses, are quintessential examples of how increased globalization has facilitated the expansion of viruses into new territories. Rapid evolution of both of these agents has contributed to their rapid spread and health burden. Thus, characterizing how selection shapes zoonotic RNA viruses in their natural hosts is important to understand their emergence. As an ecological generalist able to infect hundreds of bird species, WNV is an excellent tool to study how different animal hosts can differentially drive virus evolution. We examined the genetic composition and fitness of WNV produced during replication in wild-caught American crows, house sparrows and American robins, species that range in mortality following WNV infection (crows the highest, robins the lowest). We demonstrate host-dependent effects on WNV population structure and fitness. Our study provides insights on how different virus-animal interactions can influence the success of a virus in the next host and ultimately the success of virus emergence into new host systems.

12 September 2021 in Viruses
Verified
Journal Article
Open access
PDF file
GGGrace Goryoka
Grace Goryoka
CCCaitlin Cossaboom
Caitlin Cossaboom
RGRadhika Gharpure
Radhika Gharpure
PDPatrick Dawson
Patrick Dawson
CTCassandra Tansey
Cassandra Tansey
CBCasey Barton Behravesh
Casey Barton Behravesh
Approximately 67% of U.S. households have pets. Limited data are available on SARS-CoV-2 in pets. We assessed SARS-CoV-2 infection in pets during a COVID-19 household transmission investigation. Pets from households with ≥1 person with laboratory-confirmed COVID-19 were eligible for inclusion from April–May 2020. We enrolled 37 dogs and 19 cats from 34 households. All oropharyngeal, nasal, and rectal swabs tested negative by rRT-PCR; one dog’s fur swabs (2%) tested positive by rRT-PCR at the first sampling. Among 47 pets with serological results, eight (17%) pets (four dogs, four cats) from 6/30 (20%) households had detectable SARS-CoV-2 neutralizing antibodies. In households with a seropositive pet, the proportion of people with laboratory-confirmed COVID-19 was greater (median 79%; range: 40–100%) compared to households with no seropositive pet (median 37%; range: 13–100%) (p = 0.01). Thirty-three pets with serologic results had frequent daily contact (≥1 h) with the index patient before the person’s COVID-19 diagnosis. Of these 33 pets, 14 (42%) had decreased contact with the index patient after diagnosis and none were seropositive; of the 19 (58%) pets with continued contact, four (21%) were seropositive. Seropositive pets likely acquired infection after contact with people with COVID-19. People with COVID-19 should restrict contact with pets and other animals.

PMPerrine Marcenac
Perrine Marcenac
GPGeun Woo Park
Geun Woo Park
LDLindsey M. Duca
Lindsey M. Duca
NLNathaniel M. Lewis
Nathaniel M. Lewis
EDElizabeth A. Dietrich
Elizabeth A. Dietrich
EPEric Pevzner
Eric Pevzner
SARS-CoV-2 transmission from contaminated surfaces, or fomites, has been a concern during the COVID-19 pandemic. Households have been important sites of transmission throughout the COVID-19 pandemic, but there is limited information on SARS-CoV-2 contamination of surfaces in these settings. We describe environmental detection of SARS-CoV-2 in households of persons with COVID-19 to better characterize the potential risks of fomite transmission. Ten households with ≥1 person with laboratory-confirmed COVID-19 and with ≥2 members total were enrolled in Utah, U.S.A. Nasopharyngeal and anterior nasal swabs were collected from members and tested for the presence of SARS-CoV-2 by RT-PCR. Fifteen surfaces were sampled in each household and tested for presence and viability of SARS-CoV-2. SARS-CoV-2 RNA was detected in 23 (15%) of 150 environmental swab samples, most frequently on nightstands (4/6; 67%), pillows (4/23; 17%), and light switches (3/21; 14%). Viable SARS-CoV-2 was cultured from one sample. All households with SARS-CoV-2-positive surfaces had ≥1 person who first tested positive for SARS-CoV-2 ≤ 6 days prior to environmental sampling. SARS-CoV-2 surface contamination occurred early in the course of infection when respiratory transmission is most likely, notably on surfaces in close, prolonged contact with persons with COVID-19. While fomite transmission might be possible, risk is low.

1 January 2009 in Mucosal Immunology
Verified
Journal Article
Closed access
AZA A Zaia
A A Zaia
KSK J Sappington
K J Sappington
KNK Nisapakultorn
K Nisapakultorn
WCW J Chazin
W J Chazin
EDE A Dietrich
E A Dietrich
MHM C Herzberg
M C Herzberg

7 November 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
WBWhitney R. Baldwin
Whitney R. Baldwin
JLJill A. Livengood
Jill A. Livengood
HGHolli A. Giebler
Holli A. Giebler
JSJanae L. Stovall
Janae L. Stovall
KBKaren L. Boroughs
Karen L. Boroughs
HDHansi J. Dean
Hansi J. Dean
In response to the 2016 global public health emergency of international concern announced by the World Health Organization surrounding Zika virus (ZIKV) outbreaks, we developed a purified inactivated Zika virus vaccine (PIZV) candidate from ZIKV strain PRVABC59, isolated during the outbreak in 2015. The virus isolate was plaque purified, creating six sub-isolated virus stocks, two of which were selected to generate PIZV candidates for preclinical immunogenicity and efficacy evaluation in mice. The alum-adjuvanted PIZV candidates were highly immunogenic in both CD-1 and AG129 mice after a 2-dose immunization. Further, AG129 mice receiving 2 doses of PIZV formulated with alum were fully protected against lethal ZIKV challenge and mouse immune sera elicited by the PIZV candidates were capable of neutralizing ZIKVs of both African and Asian genetic lineages in vitro. Additionally, passive immunization of naïve mice with ZIKV-immune serum showed strong positive correlation between neutralizing ZIKV antibody (NAb) titers and protection against lethal challenge. This study supported advancement of the PIZV candidate toward clinical development.

1 October 2011 in Journal of Virology
Verified
Journal Article
Closed access
EDElizabeth A. Dietrich
Elizabeth A. Dietrich
Greg BrennanGreg Brennan
Greg Brennan
BFBetsy Ferguson
Betsy Ferguson
RWRoger W. Wiseman
Roger W. Wiseman
DODavid O'Connor
David O'Connor
SHShiu-Lok Hu
Shiu-Lok Hu
The retroviral restriction factor TRIMCyp, derived from the TRIM5 gene, blocks replication at a postentry step. TRIMCyp has so far been found in four species of Asian macaques, Macaca fascicularis , M. mulatta , M. nemestrina , and M. leonina . M. fascicularis is commonly used as a model for AIDS research, but TRIMCyp has not been analyzed in detail in this species. We analyzed the prevalence of TRIMCyp in samples from Indonesia, Indochina, the Philippines, and Mauritius. We found that TRIMCyp is present at a higher frequency in Indonesian than in Indochinese M. fascicularis macaques and is also present in samples from the Philippines. TRIMCyp is absent in Mauritian M. fascicularis macaques. We then analyzed the restriction specificity of TRIMCyp derived from three animals of Indonesian origin. One allele, like the prototypic TRIMCyp alleles described for M. mulatta and M. nemestrina , restricts human immunodeficiency virus type 2 (HIV-2) and feline immunodeficiency virus (FIV) but not HIV-1. The others restrict HIV-1 and FIV but not HIV-2. Mutagenesis studies confirmed that polymorphisms at amino acid residues 369 and 446 in TRIMCyp (or residues 66 and 143 in the cyclophilin A [CypA] domain) confer restriction specificity. Additionally, we identified a polymorphism in the coiled-coil domain that appears to affect TRIMCyp expression or stability. Taken together, these data show that M. fascicularis has the most diverse array of TRIM5 restriction factors described for any primate species to date. These findings are relevant to our understanding of the evolution of retroviral restriction factors and the use of M. fascicularis models in AIDS research.